Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220004964 220001950 1.74 58 Palliative (P) 2015-12-29 2015-12-29 Trial Unspecified Y N 220027169 TRIAL
220004965 220001950 1.74 null Palliative (P) null 2016-08-17 CYTARABINE 02 N 220027169 CYTARABINE
220004966 220001950 null 72 Not known (9) 2016-05-06 2016-05-06 AML17 TRIAL null null 220027169 AML17 TRIAL
220004967 220001950 null 69.9 Curative (C) null 2013-09-09 AML17 TRIAL null null 220027169 AML17 TRIAL
220004968 220001950 null 80 Disease modification (D) 2015-11-18 2016-02-22 Trial Unspecified Y N 220027169 TRIAL
220004969 220001950 null null Palliative (P) 2013-08-28 2013-08-28 Cytarabine low (10to20mg/m2) IV/SC 2 N 220027169 CYTARABINE
220004970 220001951 null 61.5 Not known (9) 2013-12-05 2013-12-14 CYTARABINE N N 220027184 CYTARABINE
220004971 220001951 1.7 71.5 Curative (C) null 2015-02-15 Trial Unspecified N N 220027184 TRIAL
220004972 220001951 null null Disease modification (D) 2015-12-04 2015-12-09 Cytarabine Low Dose 02 N 220027184 CYTARABINE
220004973 220001952 1.65 94.1 Curative (C) 2013-10-14 2013-10-14 Trial Unspecified Y N 220027192 TRIAL
220004974 220001953 1.48 62.7 null 2013-12-16 2013-12-19 Cytarabine low (10to20mg/m2) IV/SC N N 220027194 CYTARABINE
220004975 220001953 1.65 62.4 Curative (C) 2016-10-29 2016-10-29 AML17 TRIAL 1 null 220027194 AML17 TRIAL
220004976 220001954 null 68 Curative (C) 2015-02-18 2015-04-08 Cytarabine Low Dose 02 N 220027199 CYTARABINE
220004977 220001955 1.83 119.5 Palliative (P) 2017-05-15 2017-05-17 Trial Unspecified Y N 220027200 TRIAL
220004978 220001956 null 88.6 Curative (C) 2016-11-18 2016-11-18 AML17 TRIAL N N 220027201 AML17 TRIAL
220004979 220011020 1.58 69.8 Curative (C) 2014-06-02 2014-06-03 AML17 TRIAL 01 null 220027204 AML17 TRIAL
220004980 220001957 1.7 null null 2013-12-28 2013-12-28 Cytarabine Low Dose N N 220027205 CYTARABINE
220004983 220001958 1.83 null Palliative (P) 2015-01-28 2015-01-29 Cytarabine Low Dose 2 N 220027212 CYTARABINE
220004984 220001958 1.7 63.3 null null 2015-11-23 Cytarabine Low Dose 02 N 220027212 CYTARABINE
220004985 220001958 1.79 0 Palliative (P) 2015-09-13 2015-09-16 CYTARABINE null null 220027212 CYTARABINE
220004986 220001959 null 87.6 Radical (R) 2013-12-03 2013-12-05 AML17 TRIAL 1 null 220027215 AML17 TRIAL
220004987 220001959 1.56 null Curative (C) 2013-06-05 2013-06-05 AML17 TRIAL N N 220027215 AML17 TRIAL
220004988 220001959 null null Curative (C) 2013-05-31 2013-05-31 AML17 TRIAL 1 null 220027215 AML17 TRIAL
220004989 220001960 1.66 98 Adjuvant (A) 2015-09-10 2015-09-25 AML17 TRIAL N N 220027219 AML17 TRIAL
220004990 220001960 1.78 null null 2016-04-24 2016-05-04 Cytarabine Low Dose 99 N 220027219 CYTARABINE
220004991 220001960 null 79.8 Curative (C) 2016-10-08 2017-03-16 Cytarabine Low Dose N N 220027219 CYTARABINE
220004992 220001960 null 64.3 Disease modification (D) 2017-05-31 2017-05-31 Cytarabine Low Dose 2 N 220027219 CYTARABINE
220004993 220020301 1.62 55 null 2016-10-29 2016-10-29 AML17 TRIAL 01 N 220027227 AML17 TRIAL
220004994 220001961 null 77 Palliative (P) null 2016-11-30 LI-1 TRIAL null null 220027228 TRIAL
220004995 220001961 1.77 null Palliative (P) 2014-04-05 2014-04-10 Cytarabine Low Dose N N 220027228 CYTARABINE
220004996 220001961 1.8 91 Curative (C) 2016-12-26 2016-12-27 Trial Unspecified Y N 220027228 TRIAL
220005001 220001963 1.78 77 Curative (C) 2012-08-14 2013-04-24 AML17 TRIAL N N 220027247 AML17 TRIAL
220005002 220001963 1.79 null Not known (9) 2014-07-16 2014-07-16 AML17 TRIAL N N 220027247 AML17 TRIAL
220005003 220001964 null 86.1 null 2013-12-01 2013-12-01 Cytarabine low (10to20mg/m2) IV/SC N N 220027251 CYTARABINE
220005004 220001965 1.77 67.5 null 2015-01-06 2015-01-06 Trial Unspecified 01 null 220027252 TRIAL
220005005 220001965 1.69 null Curative (C) 2013-09-28 2013-09-28 AML17 TRIAL Y N 220027252 AML17 TRIAL
220005006 220001965 1.65 null Palliative (P) null 2017-08-13 CYTARABINE null null 220027252 CYTARABINE
220005007 220001965 1.69 45.4 Disease modification (D) 2014-06-05 2014-06-05 LI-1 TRIAL 01 N 220027252 TRIAL
220005008 220001966 0 58.4 Curative (C) 2017-01-29 2017-01-29 AML17 TRIAL 01 null 220027260 AML17 TRIAL
220005009 220011029 1.78 67.8 Not known (9) 2017-03-31 2017-04-01 AML17 TRIAL 02 N 220027261 AML17 TRIAL
220005010 220011029 null 0 Curative (C) 2015-05-22 2015-05-28 LI-1 TRIAL Y N 220027261 TRIAL
220005011 220001967 1.6 0 Palliative (P) 2015-02-09 2015-02-20 Trial Unspecified 01 N 220027263 TRIAL
220005012 220001967 1.7 81 null 2017-12-09 2017-12-09 Cytarabine low (10to20mg/m2) IV/SC N N 220027263 CYTARABINE
220005017 220001969 null null null null 2013-04-03 CYTARABINE null null 220027280 CYTARABINE
220005018 220001969 1.48 null Palliative (P) 2016-01-13 2016-01-13 CYTARABINE N N 220027280 CYTARABINE
220005019 220001970 1.56 60 Curative (C) null 2013-06-21 AML17 TRIAL null null 220027283 AML17 TRIAL
220005020 220001971 1.75 83 Disease modification (D) 2015-07-25 2015-07-25 Trial Unspecified Y N 220027289 TRIAL
220005021 220001971 null null Curative (C) 2014-05-01 2014-05-02 AML17 TRIAL 1 N 220027289 AML17 TRIAL
220005022 220001972 1.57 0 Adjuvant (A) 2015-04-02 2015-04-02 Trial Unspecified Y N 220027295 TRIAL
220005023 220001973 1.72 null Curative (C) 2017-04-08 2017-04-08 AML17 TRIAL N N 220027297 AML17 TRIAL